📣 VC round data is live. Check it out!
- Public Comps
- MeVis
MeVis Valuation Multiples
Discover revenue and EBITDA valuation multiples for MeVis and similar public comparables like SOFTMAX, BIT Computer, PharmX Technologies, HeartBeam and more.
MeVis Overview
About MeVis
MeVis Medical Solutions AG is a provider of medical software products. The company markets its products to equipment manufacturer of medical devices and providers of medical information technology platforms. Its segment includes Digital mammography and Other diagnostics. The Digital mammography segment develops and markets software products which assist in breast diagnostic imaging and intervention. Its Other diagnostics segment consists of digital radiology products. In addition, it also provides the general analysis of radiology images. The company's geographical area of operations includes the United States of America and Europe.
Founded
1997
HQ

Employees
94
Website
Financials (FY)
EV
$42M
Valuation Multiples
Start free trialMeVis Financials
MeVis reported last fiscal year revenue of $19M and EBITDA of $4M.
In the same fiscal year, MeVis generated $18M in gross profit, $4M in EBITDA, and $4M in net income.
Revenue (LTM)
MeVis P&L
In the most recent fiscal year, MeVis reported revenue of $19M and EBITDA of $4M.
MeVis is profitable as of last fiscal year, with gross margin of 98%, EBITDA margin of 21%, and net margin of 20%.
Financial data powered by Morningstar, Inc.
MeVis Stock Performance
MeVis has current market cap of $50M, and enterprise value of $42M.
Market Cap Evolution
MeVis' stock price is $27.41.
MeVis share price increased by 0.3% in the last 30 days, and decreased by 5.7% in the last year.
MeVis has an EPS (earnings per share) of $2.04.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $42M | $50M | 0.2% | 0.3% | -7.1% | -5.7% | $2.04 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialMeVis Valuation Multiples
MeVis trades at 2.2x EV/Revenue multiple, and 10.5x EV/EBITDA.
EV / Revenue (LTM)
MeVis Financial Valuation Multiples
As of May 8, 2026, MeVis has market cap of $50M and EV of $42M.
MeVis has a P/E ratio of 13.5x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified MeVis Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


MeVis Margins & Growth Rates
In the most recent fiscal year, MeVis reported gross margin of 98%, EBITDA margin of 21%, and net margin of 20%.
MeVis Margins
MeVis Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
MeVis Operational KPIs
MeVis' revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.2M for the same period.
Data powered by FactSet, Inc. and Morningstar, Inc.
MeVis Competitors
MeVis competitors include SOFTMAX, BIT Computer, PharmX Technologies, HeartBeam, Mach7 Technologies, Deepnoid, SMAIO, EUDA Health, INIFY Laboratories and Vanfund Urban Investment.
Most MeVis public comparables operate across Healthcare Software, Medical Imaging & Diagnostics, B2B SaaS, Vertical SaaS and HealthTech.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 1.1x | 1.1x | 9.2x | — | |||
| 1.4x | — | 4.9x | — | |||
| 10.0x | — | 52.8x | — | |||
| — | 58.9x | (1.9x) | (1.7x) | |||
| 1.9x | 1.6x | (27.0x) | (20.6x) | |||
| 8.9x | — | (7.0x) | — | |||
| 5.2x | 4.6x | (53.9x) | (56.8x) | |||
| 6.3x | — | (20.5x) | — | |||
This data is available for Pro users. Sign up to see all MeVis competitors and their valuation data. Start Free Trial | ||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout MeVis
| When was MeVis founded? | MeVis was founded in 1997. |
| Where is MeVis headquartered? | MeVis is headquartered in Germany. |
| How many employees does MeVis have? | As of today, MeVis has over 94 employees. |
| Is MeVis publicly listed? | Yes, MeVis is a public company listed on Frankfurt Stock Exchange. |
| What is the stock symbol of MeVis? | MeVis trades under M3V ticker. |
| When did MeVis go public? | MeVis went public in 2007. |
| Who are competitors of MeVis? | MeVis main competitors include SOFTMAX, BIT Computer, PharmX Technologies, HeartBeam, Mach7 Technologies, Deepnoid, SMAIO, EUDA Health, INIFY Laboratories, Vanfund Urban Investment. |
| What is the current market cap of MeVis? | MeVis' current market cap is $50M. |
| What is the current revenue of MeVis? | MeVis' last fiscal year revenue is $19M. |
| What is the current EV/Revenue multiple of MeVis? | Current revenue multiple of MeVis is 2.2x. |
| Is MeVis profitable? | No, MeVis is not profitable. |
| How many companies MeVis has acquired to date? | MeVis hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies MeVis has invested to date? | MeVis hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to MeVis
Lists including MeVis
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.